In conclusion, the present study demonstrated that Lobetyolin exhibited anti‐cancer effect on colon cancer HCT‐116 cells through the apoptosis regulated by ASCT2‐modulated glutamine metabolism, which was governed by p53. Here, TP53 is linked to malignant colon neoplasm.